TREATMENT OF METASTATIC PROSTATE CANCER: Lessons from the Androgen Receptor
- 1 June 1996
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 10 (3) , 713-725
- https://doi.org/10.1016/s0889-8588(05)70363-4
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- A transcriptional co-repressor that interacts with nuclear hormone receptorsNature, 1995
- Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-αNature, 1995
- Management of Cancer of the ProstateNew England Journal of Medicine, 1994
- Cancer statistics, 1994CA: A Cancer Journal for Clinicians, 1994
- Casodex–-mechanisms of action and opportunities for usageCancer, 1993
- Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesteroneMolecular Endocrinology, 1993
- Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigenCancer, 1993
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic CarcinomaNew England Journal of Medicine, 1989
- A Study of Aminoglutethemide and Hydrocortisone in Patients with Advanced and Refractory Prostate CarcinomaAmerican Journal of Clinical Oncology, 1989
- Gene regulation by steroid hormonesCell, 1989